474 related articles for article (PubMed ID: 28130548)
1. Allosteric "beta-blocker" isolated from a DNA-encoded small molecule library.
Ahn S; Kahsai AW; Pani B; Wang QT; Zhao S; Wall AL; Strachan RT; Staus DP; Wingler LM; Sun LD; Sinnaeve J; Choi M; Cho T; Xu TT; Hansen GM; Burnett MB; Lamerdin JE; Bassoni DL; Gavino BJ; Husemoen G; Olsen EK; Franch T; Costanzi S; Chen X; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1708-1713. PubMed ID: 28130548
[TBL] [Abstract][Full Text] [Related]
2. Small-Molecule Positive Allosteric Modulators of the
Ahn S; Pani B; Kahsai AW; Olsen EK; Husemoen G; Vestergaard M; Jin L; Zhao S; Wingler LM; Rambarat PK; Simhal RK; Xu TT; Sun LD; Shim PJ; Staus DP; Huang LY; Franch T; Chen X; Lefkowitz RJ
Mol Pharmacol; 2018 Aug; 94(2):850-861. PubMed ID: 29769246
[TBL] [Abstract][Full Text] [Related]
3. Unique Positive Cooperativity Between the
Pani B; Ahn S; Rambarat PK; Vege S; Kahsai AW; Liu A; Valan BN; Staus DP; Costa T; Lefkowitz RJ
Mol Pharmacol; 2021 Nov; 100(5):513-525. PubMed ID: 34580163
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of intracellular allosteric β
Liu X; Ahn S; Kahsai AW; Meng KC; Latorraca NR; Pani B; Venkatakrishnan AJ; Masoudi A; Weis WI; Dror RO; Chen X; Lefkowitz RJ; Kobilka BK
Nature; 2017 Aug; 548(7668):480-484. PubMed ID: 28813418
[TBL] [Abstract][Full Text] [Related]
5. Identification of a β-arrestin-biased negative allosteric modulator for the β
Ippolito M; De Pascali F; Hopfinger N; Komolov KE; Laurinavichyute D; Reddy PAN; Sakkal LA; Rajkowski KZ; Nayak AP; Lee J; Lee J; Cao G; Donover PS; Reichman M; An SS; Salvino JM; Penn RB; Armen RS; Scott CP; Benovic JL
Proc Natl Acad Sci U S A; 2023 Aug; 120(31):e2302668120. PubMed ID: 37490535
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and functional assessment of Cmpd-15 derivatives as negative allosteric modulators for the β
Meng K; Shim P; Wang Q; Zhao S; Gu T; Kahsai AW; Ahn S; Chen X
Bioorg Med Chem; 2018 May; 26(9):2320-2330. PubMed ID: 29588128
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of pepducins as Gs-biased allosteric agonists.
Carr R; Du Y; Quoyer J; Panettieri RA; Janz JM; Bouvier M; Kobilka BK; Benovic JL
J Biol Chem; 2014 Dec; 289(52):35668-84. PubMed ID: 25395624
[TBL] [Abstract][Full Text] [Related]
8. Allosteric modulator potentiates β2AR agonist-promoted bronchoprotection in asthma models.
Ahn S; Maarsingh H; Walker JK; Liu S; Hegde A; Sumajit HC; Kahsai AW; Lefkowitz RJ
J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37432742
[TBL] [Abstract][Full Text] [Related]
9. An allosteric modulator binds to a conformational hub in the β
Liu X; Kaindl J; Korczynska M; Stößel A; Dengler D; Stanek M; Hübner H; Clark MJ; Mahoney J; Matt RA; Xu X; Hirata K; Shoichet BK; Sunahara RK; Kobilka BK; Gmeiner P
Nat Chem Biol; 2020 Jul; 16(7):749-755. PubMed ID: 32483378
[TBL] [Abstract][Full Text] [Related]
10. Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation.
Staus DP; Strachan RT; Manglik A; Pani B; Kahsai AW; Kim TH; Wingler LM; Ahn S; Chatterjee A; Masoudi A; Kruse AC; Pardon E; Steyaert J; Weis WI; Prosser RS; Kobilka BK; Costa T; Lefkowitz RJ
Nature; 2016 Jul; 535(7612):448-52. PubMed ID: 27409812
[TBL] [Abstract][Full Text] [Related]
11. In silico identification of a β
Shah SD; Lind C; De Pascali F; Penn RB; MacKerell AD; Deshpande DA
Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2214024119. PubMed ID: 36449547
[TBL] [Abstract][Full Text] [Related]
12. Tyr199 in transmembrane domain 5 of the beta2-adrenergic receptor interacts directly with the pharmacophore of a unique fluorenone-based antagonist.
Wu Z; Thiriot DS; Ruoho AE
Biochem J; 2001 Mar; 354(Pt 3):485-91. PubMed ID: 11237852
[TBL] [Abstract][Full Text] [Related]
13. Regulation of β2-adrenergic receptor function by conformationally selective single-domain intrabodies.
Staus DP; Wingler LM; Strachan RT; Rasmussen SG; Pardon E; Ahn S; Steyaert J; Kobilka BK; Lefkowitz RJ
Mol Pharmacol; 2014 Mar; 85(3):472-81. PubMed ID: 24319111
[TBL] [Abstract][Full Text] [Related]
14. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.
Rosenbaum DM; Cherezov V; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Yao XJ; Weis WI; Stevens RC; Kobilka BK
Science; 2007 Nov; 318(5854):1266-73. PubMed ID: 17962519
[TBL] [Abstract][Full Text] [Related]
15. Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.
Lane JR; Chubukov P; Liu W; Canals M; Cherezov V; Abagyan R; Stevens RC; Katritch V
Mol Pharmacol; 2013 Dec; 84(6):794-807. PubMed ID: 24021214
[TBL] [Abstract][Full Text] [Related]
16.
Wang J; Pani B; Gokhan I; Xiong X; Kahsai AW; Jiang H; Ahn S; Lefkowitz RJ; Rockman HA
Mol Pharmacol; 2021 Dec; 100(6):568-579. PubMed ID: 34561298
[No Abstract] [Full Text] [Related]
17. Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The Beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor.
Seifert R; Wenzel-Seifert K; Lee TW; Gether U; Sanders-Bush E; Kobilka BK
J Biol Chem; 1998 May; 273(18):5109-16. PubMed ID: 9556548
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of β
Liu X; Masoudi A; Kahsai AW; Huang LY; Pani B; Staus DP; Shim PJ; Hirata K; Simhal RK; Schwalb AM; Rambarat PK; Ahn S; Lefkowitz RJ; Kobilka B
Science; 2019 Jun; 364(6447):1283-1287. PubMed ID: 31249059
[TBL] [Abstract][Full Text] [Related]
19. Interaction of fenoterol stereoisomers with β2-adrenoceptor-G sα fusion proteins: antagonist and agonist competition binding.
Reinartz MT; Kälble S; Wainer IW; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):517-24. PubMed ID: 25637582
[TBL] [Abstract][Full Text] [Related]
20. Identification of an allosteric binding site for Zn2+ on the beta2 adrenergic receptor.
Swaminath G; Lee TW; Kobilka B
J Biol Chem; 2003 Jan; 278(1):352-6. PubMed ID: 12409304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
